ATG-F

anti-thymocyte globulin fragment F · Astellas Pharma China, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ATG-F, covering 2015-04-21 to 2024-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients